RGC — Regencell Bioscience Holdings Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Regencell Bioscience Holdings, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 16.4 | 11.6 | 7.96 | 4.9 | 14.2 |
| Prepaid Expenses | |||||
| Total Current Assets | 16.4 | 11.6 | 8.11 | 4.9 | 14.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.46 | 0.892 | 0.227 | 0.76 | 0.431 |
| Other Long Term Assets | |||||
| Total Assets | 18 | 12.6 | 8.44 | 5.76 | 14.7 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.578 | 0.607 | 0.194 | 0.664 | 1.32 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.953 | 0.591 | 0.22 | 0.895 | 1.38 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 17.1 | 12 | 8.22 | 4.86 | 13.3 |
| Total Liabilities & Shareholders' Equity | 18 | 12.6 | 8.44 | 5.76 | 14.7 |
| Total Common Shares Outstanding |